Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Microbot Medical Inc.

< Previous 1 2 3 Next >
Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Expand IP protection in Japan
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Final Data From Its Recent Animal Study
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Gerry O’Sullivan, the Latest Member to Join Microbot Medical’s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical’s Chief Medical Officer Dr. Eyal Morag to Highlight Performance, Safety and Usability Benefits of the LIBERTY® Robotic System During Podium Presentation at Prestigious Robotics Conference
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.